Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-09-10
2008-11-11
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S410000, C540S145000
Reexamination Certificate
active
07449454
ABSTRACT:
Novel derivatives of metallotexaphyrins are prepared by modifying the apical ligands associated with the central metal component of a metallotexaphyrin.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 4326525 (1982-04-01), Swanson et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 4935498 (1990-06-01), Sessler et al.
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5001139 (1991-03-01), Lawter et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5023252 (1991-06-01), Hseih
patent: 5041078 (1991-08-01), Matthews et al.
patent: 5120411 (1992-06-01), Sessler et al.
patent: 5159065 (1992-10-01), Sessler et al.
patent: 5162509 (1992-11-01), Sessler et al.
patent: 5252720 (1993-10-01), Sessler et al.
patent: 5256399 (1993-10-01), Sessler et al.
patent: 5272142 (1993-12-01), Sessler et al.
patent: 5292414 (1994-03-01), Sessler et al.
patent: 5302714 (1994-04-01), Sessler et al.
patent: 5369101 (1994-11-01), Sessler et al.
patent: 5432171 (1995-07-01), Sessler et al.
patent: 5439570 (1995-08-01), Sessler et al.
patent: 5451576 (1995-09-01), Sessler et al.
patent: 5457183 (1995-10-01), Sessler et al.
patent: 5457195 (1995-10-01), Sessler et al.
patent: 5475104 (1995-12-01), Sessler et al.
patent: 5504205 (1996-04-01), Sessler et al.
patent: 5525325 (1996-06-01), Sessler et al.
patent: 5530123 (1996-06-01), Sessler et al.
patent: 5543123 (1996-08-01), Hofmann et al.
patent: 5559207 (1996-09-01), Sessler et al.
patent: 5565552 (1996-10-01), Magda et al.
patent: 5567687 (1996-10-01), Magda et al.
patent: 5569759 (1996-10-01), Sessler et al.
patent: 5580543 (1996-12-01), Sessler et al.
patent: 5583220 (1996-12-01), Sessler et al.
patent: 5587371 (1996-12-01), Sessler et al.
patent: 5587463 (1996-12-01), Sessler et al.
patent: 5591422 (1997-01-01), Hemmi et al.
patent: 5594136 (1997-01-01), Sessler et al.
patent: 5595726 (1997-01-01), Magda et al.
patent: 5599923 (1997-02-01), Sessler et al.
patent: 5599928 (1997-02-01), Hemmi et al.
patent: 5601802 (1997-02-01), Hemmi et al.
patent: 5607924 (1997-03-01), Magda et al.
patent: 5616345 (1997-04-01), Geoghegan et al.
patent: 5622946 (1997-04-01), Sessler et al.
patent: 5672490 (1997-09-01), Sessler et al.
patent: 5714328 (1998-02-01), Magda et al.
patent: 5775339 (1998-07-01), Woodburn et al.
patent: 5776925 (1998-07-01), Young et al.
patent: 5798491 (1998-08-01), Magda et al.
patent: 5801229 (1998-09-01), Sessler et al.
patent: 5955586 (1999-09-01), Sessler et al.
patent: 6022526 (2000-02-01), Woodburn et al.
patent: 6022959 (2000-02-01), Magda et al.
patent: 6638924 (2003-10-01), Mody et al.
patent: WO 90/10633 (1990-09-01), None
patent: WO 94/09003 (1994-04-01), None
patent: WO 94/29316 (1994-12-01), None
patent: WO 95/10307 (1995-04-01), None
patent: WO 95/21845 (1995-08-01), None
patent: WO 96/09315 (1996-03-01), None
patent: WO 96/38461 (1996-12-01), None
patent: WO 96/40253 (1996-12-01), None
patent: WO 97/26915 (1997-07-01), None
patent: WO 97/35617 (1997-10-01), None
patent: WO 97/46262 (1997-12-01), None
patent: WO 98/07733 (1998-02-01), None
patent: WO 00/01413 (2000-01-01), None
patent: WO 02/17908 (2002-03-01), None
patent: WO-02-17908 (2002-03-01), None
patent: WO-02-39953 (2002-05-01), None
patent: WO-02-39953 (2003-05-01), None
Bernhard, E.J. et al., “Re-Evaluating Gadolinium (III) Texaphyrin as a Radiosensitizing Agent,” Cancer Res. 60:86-91 (2000).
Rosenthal, D.I. et al., “A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging,” Clinical Cancer Res. 5:739-745 (1999).
Synytsya, A. et al., “Interaction of metallotexaphyrins with mono- and polysaccharides,” J. CHem. Soc., Perking Trans. 2:1876-1884 (2000) + Abstract from CAPLUS.
Viala, J. et al., “Phases 1B and II Multidose Trial of Gadolinium Texaphyrin, a Radiation Sensitizer Detectable at MR Imaging: Preliminary Results in Brain Metastases,” Radiology 212:755-759 (1999).
Garini et al., Spectral Bioimaging, John Wiley & Sons, New York, NY, pp. 87-124 (1996).
Rockwell et al., “Growth and Cell Population Kinetics of Single and Multiple KHT Sarcomas,” Cell Tissue Kinetics, vol. 1, pp. 449-457 (1972).
PCT International Search Report dated Dec. 31, 2001, from International Application No. PCT/US01/26885, International Publication No. WO 02/17908, published Mar. 7, 2002.
Galanter Joshua
Mody Tarak D.
Pharmacyclics Inc.
Ward Paul V.
Wilson James O.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Metallotexaphyrin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metallotexaphyrin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metallotexaphyrin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027411